Zenotech Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE486F01012
  • NSEID:
  • BSEID: 532039
INR
38.16
-0.44 (-1.14%)
BSENSE

Nov 20

BSE+NSE Vol: 5.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 683231,
    "name": "Zenotech Lab.",
    "stock_name": "Zenotech Lab.",
    "full_name": "Zenotech Laboratories Ltd",
    "name_url": "stocks-analysis/zenotech-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "38.16",
    "chg": -0.44,
    "chgp": "-1.14%",
    "dir": -1,
    "prev_price": "38.60",
    "mcapval": "231.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532039,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE486F01012",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "5.77 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/zenotech-lab-683231-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zenotech Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-4257965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZenotechLaborat_mojoScore_4257965.png",
        "date": "2026-11-11 10:10:24",
        "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Zenotech Laboratories Ltd Valuation Shifts Signal Elevated Risk Amid Sector Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zenotech-laboratories-ltd-valuation-shifts-signal-elevated-risk-amid-sector-challenges-4243911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZenotechLaborat_valuationdot_4243911.png",
        "date": "2026-10-30 08:01:53",
        "description": "Zenotech Laboratories Ltd has experienced a marked deterioration in its valuation parameters, shifting from a previously expensive profile to a risky classification. This change, coupled with negative returns relative to the Sensex and underwhelming profitability metrics, raises significant concerns for investors within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-4241894",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZenotechLaborat_mojoScore_4241894.png",
        "date": "2026-10-28 10:10:44",
        "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 September 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 28 October 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-4228332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZenotechLaborat_mojoScore_4228332.png",
        "date": "2026-10-17 10:10:31",
        "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 September 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 17 October 2026, providing investors with the latest view of the company’s position."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-strong-sell-4216094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ZenotechLaborat_mojoScore_4216094.png",
        "date": "2026-10-06 10:10:36",
        "description": "Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Zenotech Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zenotech-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-4210270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ZenotechLaborat_dealthcross_4210270.png",
        "date": "2026-09-30 18:00:42",
        "description": "Zenotech Laboratories Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about sustained bearish momentum in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-4204384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ZenotechLaborat_mojoScore_4204384.png",
        "date": "2026-09-25 08:16:56",
        "description": "Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, negative earnings performance, and a shift towards bearish technical signals, signalling heightened caution for investors in this micro-cap pharmaceutical stock."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-4203461",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ZenotechLaborat_mojoScore_4203461.png",
        "date": "2026-09-24 10:11:20",
        "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 24 September 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-4192087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ZenotechLaborat_mojoScore_4192087.png",
        "date": "2026-09-13 10:10:04",
        "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 38,
    "sid": "683231",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/zenotech-laboratories-683231"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.",
      "datetime": "28-Oct-2026",
      "details": "Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026",
      "datetime": "28-Oct-2026",
      "details": "Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.",
      "datetime": "17-Oct-2026",
      "details": "Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Zenotech Laboratories Ltd has announced <strong>17:22</strong> rights issue, ex-date: 01 Jun 17",
          "dt": "2017-06-01",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.

28-Oct-2026 | Source : BSE

Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.

Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026

28-Oct-2026 | Source : BSE

Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.

Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.

17-Oct-2026 | Source : BSE

Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the quarter and half year ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Zenotech Laboratories Ltd has announced 17:22 rights issue, ex-date: 01 Jun 17